Category Archives: Doctrine of equivalents

DC decision that Invidior’s Suboxone® sublingual film patents are infringed by certain parties and not invalid for obviousness affirmed

Invidior Inc. et al. v. Dr. Reddy’s Labs. (DRL), Actavis/Watson, Teva, Par, Intelgenx, Alvogen Pine Brook, LLC Docket Nos. 2017-2587, 2018-1010, -1058, -1062, -1114, -1115, -1176, -1177 Newman, Mayer (D), Lourie July 12, 2019 Brief Summary: DC findings that Invidior … Continue reading

Posted in Claim Construction, Doctrine of equivalents, Generics / ANDA, Obviousness, Written description | Leave a comment

Amgen, Inc. et al. v. Sandoz Inc. et al.

Docket Nos. 2018-1551 and -1552 LOURIE, O’MALLEY, REYNA May 8, 2019 Brief summary: DC claim construction findings and grant of SJ of non-infringement to Sandoz regarding its Neupogen® and Neulasta® biosimilars affirmed. Summary: Amgen appealed two DC decisions finding Sandoz’s … Continue reading

Posted in Biosimilars, Claim Construction, Collateral estoppel, Doctrine of equivalents, Generics / ANDA, Infringement | Leave a comment

Power Integrations, Inc. v. Fairchild Semiconductor Int., et al.

Docket No. 2016-2691, 2017-1875 DYK, CLEVENGER, CHEN July 3, 2018 (updated September 25, 2018) Update: Original opinion modified on Sept. 20, 2018 following a petition for rehearing filed by Power Integrations (PI) but the same decisions were reached (DC claim … Continue reading

Posted in Claim Construction, Damages, Doctrine of equivalents, Infringement, Royalties | Leave a comment

Power Integrations, Inc. v. Fairchild Semiconductor Int., et al.

Docket No. 2016-2691, 2017-1875 DYK, CLEVENGER, CHEN July 3, 2018 Brief summary: DC claim constructions affirmed (e.g., no prosecution history estoppel) but damages determination based on the “entire market value rule” vacated and remanded since, e.g., PI “did not meet … Continue reading

Posted in Claim Construction, Damages, Doctrine of equivalents, Infringement, Prosecution History Estoppel, Royalties | Leave a comment

Richard J. Baker v. Microsoft Corp. et al. (Nintendo of America, Inc.)

Docket No. 2017-2357 REYNA, WALLACH, HUGHES April 9, 2018 Non-precedential Brief summary: DC grant of SJ of noninfringement to MSFT et al. based on its construction of the claim term “remote” based in part on prosecution history estoppel affirmed. Summary: … Continue reading

Posted in Claim Construction, Doctrine of equivalents, Infringement, Prosecution History Estoppel, Summary Judgment | Leave a comment

Nalco Company v. Chem-Med, LLC et al. (24 other parties)

Docket No. 2017-1036 MOORE, SCHALL, O’MALLEY February 27, 2018 Brief summary: DC dismissal of Nalco’s complaint for failing to properly allege infringement reversed and remanded since “[t]he ‘purpose of a motion to dismiss is to test the sufficiency of the … Continue reading

Posted in Appeal, Contributory Infringement, Doctrine of equivalents, Inducement to Infringe, Infringement | Leave a comment

Rembrandt Patent Innovations, LLC et al. v. Apple, Inc.

Docket No. 2016-2324 PROST, CHEN, HUGHES November 22, 2017 Non-precedential Brief summary: DC claim construction and finding of no infringement by Apple affirmed. Summary: Rembrandt appealed DC grant of SJ of noninfringement by Apple’s “mobile products” (iPhone, iPad, and iTouch) … Continue reading

Posted in Claim Construction, Doctrine of equivalents, Infringement | Leave a comment